Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jeena Sikho LifecareNSE:JSLL -1.24%84 Capex-to-Operating-Cash-Flow is 0.00 as of Jun. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 84/100 and a GF Value™ of ₹813.70 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 393 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks worse than 254452.67% on this metric.
Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.
Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.
Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.
Jeena Sikho Lifecare Capex-to-Operating-Cash-Flow Related Terms
Jeena Sikho Lifecare Capex-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's Capex-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, EHC: Capex-to-Operating-Cash-Flow Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare Capex-to-Operating-Cash-Flow vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's Capex-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's Capex-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Cash-Flow of 0.00 mean?
Jeena Sikho Lifecare (NSE:JSLL) has a Capex-to-Operating-Cash-Flow of 0.00 as of Jun. 2026. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Jeena Sikho Lifecare and its competitors. Over the past decade, Jeena Sikho Lifecare's Capex-to-Operating-Cash-Flow has ranged from 0.13 to 8.32. According to the industry distribution chart, Jeena Sikho Lifecare ranks #999999 out of 393 companies in the Healthcare Providers & Services industry.
Is Jeena Sikho Lifecare's Capex-to-Operating-Cash-Flow too high?
Jeena Sikho Lifecare's current Capex-to-Operating-Cash-Flow is 0.00. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 8.32. Based on the distribution chart, Jeena Sikho Lifecare ranks #999999 out of 393 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Capex-to-Operating-Cash-Flow compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #999999 out of 393 companies for Capex-to-Operating-Cash-Flow. This places Jeena Sikho Lifecare in the lower half of its industry. The industry median Capex-to-Operating-Cash-Flow is 0.34. Historically, Jeena Sikho Lifecare's own Capex-to-Operating-Cash-Flow has ranged from 0.13 to 8.32 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Cash-Flow for a Healthcare Providers & Services company?
The median Capex-to-Operating-Cash-Flow among Healthcare Providers & Services companies is 0.34, based on 393 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Cash-Flow mean?
A high Capex-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median Capex-to-Operating-Cash-Flow is 0.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current Capex-to-Operating-Cash-Flow is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹813.70, compared to a current price of ₹511.85 — trading 37.1% below its estimated fair value. The current Capex-to-Operating-Cash-Flow is 0.00. Jeena Sikho Lifecare's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Cash-Flow calculated?
Capex-to-Operating-Cash-Flow is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Capex-to-Operating-Cash-Flow is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹511.85 is trading 37.1% below its estimated GF Value™ of ₹813.70.
GuruFocus considers Jeena Sikho Lifecare to be Significantly Undervalued.
Key valuation signals for NSE:JSLL:
Capex-to-Operating-Cash-Flow: 0.00
GF Value™: ₹813.70 vs. price of ₹511.85 (37.1% below fair value)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
84GF Score
Get the complete analysis for NSE:JSLL
Capex-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
